PCN8 COMPARING PATIENT-RELEVANT ENDPOINT WITH CLINICAL ENDPOINT IN A RARE DISEASE: THE CASE OF METASTATIC MERKEL CELL CARCINOMA TREATED WITH AVELUMAB

May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.1515
https://www.valueinhealthjournal.com/article/S1098-3015(20)31740-X/fulltext
Section Title :
Section Order : 10666
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)31740-X&doi=10.1016/j.jval.2020.04.1515
HEOR Topics :
Tags :
Regions :